Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
46.1M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
3.27M
-
Shares change
-
-369K
-
Total reported value, excl. options
-
$9.96M
-
Value change
-
-$1.44M
-
Number of buys
-
6
-
Number of sells
-
-11
-
Price
-
$3.05
Significant Holders of Axogen, Inc. - Common Stock, $0.01 par value (AXGN) as of Q1 2014
27 filings reported holding AXGN - Axogen, Inc. - Common Stock, $0.01 par value as of Q1 2014.
Axogen, Inc. - Common Stock, $0.01 par value (AXGN) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.27M shares
of 46.1M outstanding shares and own 7.08% of the company stock.
Largest 10 shareholders include THOMSON HORSTMANN & BRYANT INC (834K shares), FMR LLC (615K shares), SOPHROSYNE CAPITAL LLC (551K shares), PERKINS CAPITAL MANAGEMENT INC (375K shares), Pine River Capital Management L.P. (349K shares), VANGUARD GROUP INC (144K shares), Pennsylvania Trust Co (122K shares), GOLDMAN SACHS GROUP INC (103K shares), GRANITE POINT CAPITAL MANAGEMENT, L.P. (62K shares), and BANK OF AMERICA CORP /DE/ (22.8K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.